These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3771434)
21. Overview of experience with ofloxacin in respiratory tract infection. Ball P Scand J Infect Dis Suppl; 1990; 68():56-63. PubMed ID: 2218424 [TBL] [Abstract][Full Text] [Related]
22. Latamoxef (moxalactam) in acute exacerbations of chronic bronchitis. Maesen FP; Davies BI; Brouwers J; Salemans T; Nelissen-Wamper M; Debruyne H J Antimicrob Chemother; 1983 Feb; 11(2):115-23. PubMed ID: 6219980 [TBL] [Abstract][Full Text] [Related]
23. The use of quinolones in respiratory tract infections. Maesen FP; Davies BI; Geraedts WH; Baur C Drugs; 1987; 34 Suppl 1():74-9. PubMed ID: 3325259 [TBL] [Abstract][Full Text] [Related]
24. Azithromycin (CP-62,993) in acute exacerbations of chronic bronchitis: an open clinical, microbiological and pharmacokinetic study. Davies BI; Maesen FP; Gubbelmans R J Antimicrob Chemother; 1989 May; 23(5):743-51. PubMed ID: 2547747 [TBL] [Abstract][Full Text] [Related]
25. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections. Part II]. Shimada J; Ishihara R; Suzuki Y; Ishii Y; Nakazawa A; Deguchi K Jpn J Antibiot; 1997 Sep; 50(9):756-67. PubMed ID: 9394236 [TBL] [Abstract][Full Text] [Related]
26. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods. Morrissey I; Robbins M; Viljoen L; Brown DF J Antimicrob Chemother; 2005 Feb; 55(2):200-8. PubMed ID: 15649996 [TBL] [Abstract][Full Text] [Related]
27. Clinical and bacteriological experience with cefodizime in acute purulent exacerbations of chronic bronchitis. Davies BI; Maesen FP; van den Bergh JJ; Costongs RJ; Geraedts WH; Gubbelmans HL; Meek JC Infection; 1992; 20 Suppl 1():S22-5. PubMed ID: 1526671 [TBL] [Abstract][Full Text] [Related]
37. Doxycycline in the treatment of respiratory tract infections. Results of a pan-European multi-centre trial. Pestel M Chemotherapy; 1975; 21 Suppl 1():91-108. PubMed ID: 1098877 [TBL] [Abstract][Full Text] [Related]
38. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen. Enright MC; McKenzie H J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030 [TBL] [Abstract][Full Text] [Related]
39. [Resistance surveillance of major pathogens for adult community-acquired respiratory tract infections in China: a multicenter study 2012]. Zhao C; Zhang F; Wang Z; Cao B; Xu X; Sun H; Zhang R; Hu Y; Liu Z; Du Y; Chen R; Zhuo C; Su D; Liu Y; Hu B; Wang H Zhonghua Jie He He Hu Xi Za Zhi; 2015 Jan; 38(1):18-22. PubMed ID: 25791651 [TBL] [Abstract][Full Text] [Related]
40. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]